Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Evolution of risk stratification and sudden death prevention in hypertrophic cardiomyopathy: Twenty years with the implantable cardioverter-defibrillator
Barry J. Maron, Ethan J. Rowin, Martin S. Maron
Heart Rhythm (2021) Vol. 18, Iss. 6, pp. 1012-1023
Open Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

Diagnosis and Evaluation of Hypertrophic Cardiomyopathy
Barry J. Maron, Milind Y. Desai, Rick A. Nishimura, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 4, pp. 372-389
Open Access | Times Cited: 333
Management of Hypertrophic Cardiomyopathy
Barry J. Maron, Milind Y. Desai, Rick A. Nishimura, et al.
Journal of the American College of Cardiology (2022) Vol. 79, Iss. 4, pp. 390-414
Open Access | Times Cited: 253
Recommendations for Multimodality Cardiovascular Imaging of Patients with Hypertrophic Cardiomyopathy: An Update from the American Society of Echocardiography, in Collaboration with the American Society of Nuclear Cardiology, the Society for Cardiovascular Magnetic Resonance, and the Society of Cardiovascular Computed Tomography
Sherif F. Nagueh, Dermot Phelan, Theodore P. Abraham, et al.
Journal of the American Society of Echocardiography (2022) Vol. 35, Iss. 6, pp. 533-569
Open Access | Times Cited: 107
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel
Barry J. Maron, Joseph A. Dearani, Nicholas G. Smedira, et al.
The American Journal of Cardiology (2022) Vol. 180, pp. 124-139
Open Access | Times Cited: 48
Hypertrophic Cardiomyopathy: New Concepts and Therapies
Barry J. Maron, Ethan J. Rowin, Martin S. Maron
Annual Review of Medicine (2022) Vol. 73, Iss. 1, pp. 363-375
Open Access | Times Cited: 44
Southeast Asian, African, and Middle East Expert Consensus on Structured Physical Activity—Dance, Exercise, and Sports
Sarita Bajaj, Madhur Verma, Hanjabam Barun Sharma, et al.
Advances in Therapy (2025)
Closed Access | Times Cited: 1
Scar architecture affects the electrophysiological characteristics of induced ventricular arrhythmias in hypertrophic cardiomyopathy
Pietro Francia, Giulio Falasconi, Diego Penela, et al.
EP Europace (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 6
Risk factors of sudden cardiac death in hypertrophic cardiomyopathy
Ying Hong, Wilber Su, Xiaoping Li
Current Opinion in Cardiology (2021) Vol. 37, Iss. 1, pp. 15-21
Open Access | Times Cited: 33
Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Omar Abdelfattah, Matthew W. Martinez, Ahmed Sayed, et al.
JACC. Clinical electrophysiology (2022) Vol. 8, Iss. 11, pp. 1417-1427
Open Access | Times Cited: 27
Familial Hypertrophic Cardiomyopathy: Diagnosis and Management
M. Litt, Ayan Ali, Nosheen Reza
Vascular Health and Risk Management (2023) Vol. Volume 19, pp. 211-221
Open Access | Times Cited: 16
The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy
Martin S. Maron, Ethan J. Rowin, Barry J. Maron
The American Journal of Cardiology (2024) Vol. 212, pp. S64-S76
Open Access | Times Cited: 6
Development of the Implantable Cardioverter-Defibrillator
Barry J. Maron, N.A. Mark Estes, Ethan J. Rowin, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 4, pp. 353-373
Open Access | Times Cited: 13
Hypertrophic Cardiomyopathy: New Clinical and Therapeutic Perspectives of an “Old” Genetic Myocardial Disease
Chiara Calore, Mario Mangia, Cristina Basso, et al.
Genes (2025) Vol. 16, Iss. 1, pp. 74-74
Open Access
Substrates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Matteo Sclafani, Giulio Falasconi, Giacomo Tini, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1331-1331
Open Access
Complementary classification of hypertrophic cardiomyopathy using unsupervised cluster analysis on left ventricular function
Dandan Sun, Xingyu Fang, Yuzhu Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Lifetime Clinical Course of Hypertrophic Cardiomyopathy
Niccolò Maurizi, Iacopo Olivotto, Martin S. Maron, et al.
JACC Advances (2023) Vol. 2, Iss. 4, pp. 100337-100337
Open Access | Times Cited: 9
Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023
Barry J. Maron, Ethan J. Rowin, Martin S. Maron
The American Journal of Cardiology (2024) Vol. 212, pp. S77-S82
Open Access | Times Cited: 3
Left atrial and left ventricular strain in feature-tracking cardiac magnetic resonance for predicting patients at high risk of sudden cardiac death in hypertrophic cardiomyopathy
Xinyu Zhu, Ying Shi, Jianxiu Lian, et al.
Quantitative Imaging in Medicine and Surgery (2024) Vol. 14, Iss. 5, pp. 3544-3556
Open Access | Times Cited: 3
Differing strategies for sudden death prevention in hypertrophic cardiomyopathy
Martin S. Maron, Ethan J. Rowin, Paolo Spirito, et al.
Heart (2022) Vol. 109, Iss. 8, pp. 589-594
Open Access | Times Cited: 13
Importance of newer cardiac magnetic resonance–based risk markers for sudden death prevention in hypertrophic cardiomyopathy: An international multicenter study
Ethan J. Rowin, Martin S. Maron, Arnon Adler, et al.
Heart Rhythm (2021) Vol. 19, Iss. 5, pp. 782-789
Closed Access | Times Cited: 17
Contemporary review on pediatric hypertrophic cardiomyopathy: insights into detection and management
Areez Shafqat, Abdullah Shaik, Snygdha Koritala, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 10
Open Access | Times Cited: 2
Re-examining family history of sudden death as a risk marker in hypertrophic cardiomyopathy
Konstantinos C. Siontis, Steven R Ommen, Martin S. Maron, et al.
Heart Rhythm (2024) Vol. 21, Iss. 10, pp. 1838-1842
Closed Access | Times Cited: 2
Safety and efficacy of ranolazine in hypertrophic cardiomyopathy: Real-world experience in a National Referral Center
Alessia Argirò, Mattia Zampieri, L Dei, et al.
International Journal of Cardiology (2022) Vol. 370, pp. 271-278
Closed Access | Times Cited: 11
Clinical scenarios of hypertrophic cardiomyopathy-related mortality: Relevance of age and stage of disease at presentation
Mattia Zampieri, Samuele Salvi, Carlo Fumagalli, et al.
International Journal of Cardiology (2023) Vol. 374, pp. 65-72
Open Access | Times Cited: 6
Sudden cardiac death in childhood hypertrophic cardiomyopathy
Keval Thakkar, Adnan Rafiq Karajgi, Anusha Manoj Kallamvalappil, et al.
Disease-a-Month (2023) Vol. 69, Iss. 4, pp. 101548-101548
Closed Access | Times Cited: 6
Page 1 - Next Page

Scroll to top